“Live-Talk am Freitag”: Webinar on the GSAV / Pharmacy Transition
This far-reaching transition raises many questions for us. We are very pleased about the willingness of:
- Priv.-Doz. Dr. med. Jürgen Koscielny, Head of the Coagulation Outpatient Clinic with Hemophilia Treatment Center at Charité GmbH Berlin
- Claudia Neuhaus, Managing Director / Owner of the Witzleben Apotheken Berlin
- Dr. David Schmoldt, Product Owner, SMART MEDICATION, Frankfurt am Main
to get to the bottom of this topic with us in a live webinar and also answer questions from the chat.
What are the GSAV and Section 47 of the German Medicines Act (Arzneimittelgesetz)? How does the transition affect the supply of medication for people with hemophilia, von Willebrand disease, and other rare blood clotting disorders? How will care be organized as of September 1, 2020, where and how will I receive my clotting medication, and what happens in an emergency? How are the legally required batch numbers reported to the German hemophilia registry, and what role do pharmacies play in this? We will discuss such questions with these experts in the “Live-Talk am Freitag” from 6 to 7 p.m.
Further information / program
Collection of information and brochures on the GSAV